Compounds > ciprofibrate

ciprofibrate and probucol

ciprofibrate has been researched along with probucol in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	3 (37.50)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Clerc, C; Cloarec, L; Doualin, G; Fertil, V; Legras, B; Ruelland, A	1
Beaumont, JL; Beaumont, V; Buxtorf, JC; Carcone, B; Doucet, F; Edouard, L; Jacotot, B	1
Farmer, JA; Gotto, AM	1
Murphy, MJ; O'Reilly, DS; Packard, CJ	1

Reviews

1 review(s) available for ciprofibrate and probucol

Article	Year
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug safety, 1994, Volume: 11, Issue:5 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibric Acid; Colestipol; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol	1994

Trials

1 trial(s) available for ciprofibrate and probucol

Article	Year
Effects of several lipid-lowering drugs on skin total and esterified cholesterol. Monographs on atherosclerosis, 1986, Volume: 14 Topics: Cholesterol Esters; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibric Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Probucol; Random Allocation; Skin	1986

Other Studies

6 other study(ies) available for ciprofibrate and probucol

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Transitory deficit in high-density lipoproteins and apolipoprotein A-I. Clinical chemistry, 1990, Volume: 36, Issue:3 Topics: Apolipoprotein A-I; Apolipoproteins A; Bezafibrate; Clofibric Acid; Drug Therapy, Combination; Fibric Acids; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Probucol	1990
Fibrates and HDL cholesterol. Annals of clinical biochemistry, 1997, Volume: 34 ( Pt 1) Topics: Apolipoprotein A-I; Cholesterol, HDL; Clofibric Acid; Dose-Response Relationship, Drug; Female; Fenofibrate; Fibric Acids; Humans; Hypolipidemic Agents; Hypolipoproteinemias; Middle Aged; Probucol	1997